600557 Stock Overview
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Jiangsu Kanion Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.92 |
| 52 Week High | CN¥32.25 |
| 52 Week Low | CN¥13.36 |
| Beta | 0.34 |
| 1 Month Change | -15.20% |
| 3 Month Change | -1.25% |
| 1 Year Change | -39.46% |
| 3 Year Change | 87.14% |
| 5 Year Change | 38.10% |
| Change since IPO | -12.34% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600557 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.9% | -1.1% | -0.4% |
| 1Y | -39.5% | -15.9% | -16.2% |
Return vs Industry: 600557 underperformed the CN Pharmaceuticals industry which returned -16% over the past year.
Return vs Market: 600557 underperformed the CN Market which returned -17.6% over the past year.
Price Volatility
| 600557 volatility | |
|---|---|
| 600557 Average Weekly Movement | 9.1% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 600557's share price has been volatile over the past 3 months.
Volatility Over Time: 600557's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1975 | 5,443 | Yongchun Yang | www.kanion.com |
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. The company offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others.
Jiangsu Kanion Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600557 fundamental statistics | |
|---|---|
| Market cap | CN¥11.05b |
| Earnings (TTM) | CN¥543.34m |
| Revenue (TTM) | CN¥4.87b |
20.3x
P/E Ratio2.3x
P/S RatioIs 600557 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600557 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.87b |
| Cost of Revenue | CN¥1.26b |
| Gross Profit | CN¥3.61b |
| Other Expenses | CN¥3.07b |
| Earnings | CN¥543.34m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 74.08% |
| Net Profit Margin | 11.15% |
| Debt/Equity Ratio | 0.03% |
How did 600557 perform over the long term?
See historical performance and comparison